Kush Parmar, Director, 10% Owner at Homology Medicines, Inc. (FIXX), sold 1,051,800 shares at $20.20 ($21.2M) on 2018-11-16, disclosed to the SEC on 2018-11-20.
Open-market sale of $21.2M FIXX by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.20 | 21,036 | $425K | 2.0% |
| 2 | $20.20 | 21,036 | $425K | 2.0% |
| 3 | $20.20 | 504,864 | $10.2M | 48.0% |
| 4 | $20.20 | 504,864 | $10.2M | 48.0% |
| Total | $20.20 avg | 1,051,800 | $21.2M | 100% |
| Filing → |
| TRDA | SELL | 2025-11-18 | $3.5M | — | Filing → |
| TRDA | SELL | 2025-07-11 | $405K | — | Filing → |
| TRDA | SELL | 2025-07-01 | $1.6M | — | Filing → |